KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Johnson & Johnson (JNJ) EPS (Weighted Average and Diluted) (2016 - 2026)

Johnson & Johnson's EPS (Weighted Average and Diluted) history spans 18 years, with the latest figure at $2.14 for Q1 2026.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 52.86% to $2.14 in Q1 2026 year-over-year; TTM through Mar 2026 was $8.64, a 3.89% decrease, with the full-year FY2025 number at $11.03, up 90.5% from a year prior.
  • EPS (Weighted Average and Diluted) hit $2.14 in Q1 2026 for Johnson & Johnson, up from $2.09 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for JNJ hit a ceiling of $10.21 in Q4 2023 and a floor of -$0.09 in Q3 2023.
  • Historically, EPS (Weighted Average and Diluted) has averaged $2.2 across 5 years, with a median of $1.8 in 2022.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): plummeted 104.9% in 2023 and later skyrocketed 4566.67% in 2024.
  • Tracing JNJ's EPS (Weighted Average and Diluted) over 5 years: stood at $1.68 in 2022, then rose by 1.19% to $1.7 in 2023, then fell by 17.06% to $1.41 in 2024, then skyrocketed by 48.23% to $2.09 in 2025, then grew by 2.39% to $2.14 in 2026.
  • Business Quant data shows EPS (Weighted Average and Diluted) for JNJ at $2.14 in Q1 2026, $2.09 in Q4 2025, and $2.12 in Q3 2025.